Announcements Trials
Browse Landscape

Status

Not yet recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 5Thoracic Neoplasms 1Respiratory Tract Neoplasms 1Respiratory Tract Diseases 1Non-small Lung Cancer 1Neoplasms by Site 1Neoplasms 1Lung Neoplasms 1Lung Diseases 1Carcinoma, Bronchogenic 1Carcinoma 1Breast Neoplasms 1

Interventions

toripalimab 1taletrectinib 1Injections 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Non-small Lung Cancer × taletrectinib × Clear all
NCT07199010 2025-09-30

Real-world Study of Taletrectinib in Advanced ROS1+ NSCLC Following Entrectinib Progression

Innovent Biologics (Suzhou) Co. Ltd.

Not yet recruiting
50 enrolled
Thoracic

Non-small Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡